$FIG

Herb Tyler sold $18K of FIG

Herb Tyler (Chief Accounting Officer) sold 709 shares of Figma, Inc. (FIG) at $26.00 on 2026-08-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Herb Tyler
Published Aug 6, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 7:46 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FIG
Neutral
medium confidence
Mentioned
$FIG
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FIGNeutralLow
01

Why it matters

The disclosure adds transparency on insider selling activity but does not introduce new information about Figma’s business performance or guidance.

02

Market read

Traders may monitor insider activity for sentiment, but this specific filing is unlikely to drive a material repricing without accompanying company-specific news.

03

What to watch

The article does not state whether additional insider buys/sales occurred around the same period, nor does it provide context on total holdings beyond the post-transaction share count.

Relevance 2/10Novelty 3/10Timing: filed 2026-08-06, transaction dated 2026-08-04

Background

The article is an SEC Form 4 insider transaction disclosure for Figma, Inc., reported by its Chief Accounting Officer.

Company-level read

Ticker impact

$FIGNeutralMedium confidence
Context

Figma Form 4 shows CFO Herb Tyler sold 709 shares at $26.00 on 2026-08-04 under a pre-arranged 10b5-1 plan.

Expected impact

Likely minimal impact; any effect is more about optics than new company information.

Evidence & confidence

The filing discloses an insider transaction size and timing, but provides no new operational, financial, or regulatory facts about Figma.

Market effects

Insider-sale optics may slightly influence sentiment toward high-growth SaaS/design software names, but no sector-wide signal is provided.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Figma, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Herb Tyler

    Chief Accounting Officer who sold 709 shares.

Related articles

$FIGMedAI 8/10

Figma Q2 Earnings Call Highlights

Figma’s Q2 earnings call highlighted higher AI inference costs affecting operating income and free cash flow. For Q3, it forecast revenue of $373M to $375M (36% growth at midpoint). It raised full-year revenue outlook by $40M to $1.463B to $1.467B and kept non-GAAP operating income at $125M to $135M. Figma said AI credit consumption and agent adoption drove results.

$FIGHighAI 9/10

Why Figma Stock Just Sank

Figma, Inc. shares fell about 14.9% Thursday after results. The company reported Q2 revenue up 48% to just over $370M, above the $351.5M estimate, and adjusted EPS of $0.08. However, cost of revenue rose 117%, driven largely by AI infrastructure and hosting. Q3 revenue guidance was $373M to $375M. CEO Dylan Field said the CMO and CPO will leave.

$DDOGMed

Software stocks sink, led by declines from Figma, Datadog

Software stocks fell Thursday after quarterly results from Datadog, Figma, and HubSpot. Datadog shares dropped more than 15% despite beating revenue and earnings; adjusted gross margin was 80% versus 80.7% consensus. Figma also fell after warning of higher AI inference spending. iShares Expanded Tech-Software ETF (IGV) fell over 2%.

$SNDKMed

Futures Flat As Tech Slides After Memory Stocks, Korea Tumble

US stock index futures were mixed, with S&P futures up 0.1% and Nasdaq futures down 0.5% as Sandisk (SNDK) fell about 9% and Western Digital (WDC) about 15% after earnings and weaker memory outlooks. Tech and AI names also dropped on results or guidance misses, while Mag 7 were mixed. Asian markets declined after chip-related losses, and investors awaited US payrolls.